Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -0.10% | -0.10% |
May. 20 | DNA Plc Announces Changes in Executive Team | CI |
Apr. 16 | DNA Oyj Announces Change in the Executive Team | CI |
Sales 2022 | 997M 1.07B | Sales 2023 | 1.07B 1.15B | Capitalization | 2.75B 2.96B |
---|---|---|---|---|---|
Net income 2022 | 120M 129M | Net income 2023 | 146M 157M | EV / Sales 2022 | 3.4 x |
Net Debt 2022 | 634M 682M | Net Debt 2023 | 670M 721M | EV / Sales 2023 | 3.21 x |
P/E ratio 2022 |
22.9
x | P/E ratio 2023 |
18.8
x | Employees | - |
Yield 2022 |
3.65% | Yield 2023 |
2.21% | Free-Float | 98.91% |
Managers | Title | Age | Since |
---|---|---|---|
Jussi Tolvanen
CEO | Chief Executive Officer | 46 | 21-09-30 |
Taneli Ropponen
CTO | Chief Tech/Sci/R&D Officer | 57 | - |
Anna Anttinen
IRO | Public Communications Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 58 | 19-10-30 | |
Director/Board Member | 59 | - | |
Thomas Thyholdt
BRD | Director/Board Member | 49 | - |
- Stock Market
- Equities
- DNA Stock